methyl salicylate has been researched along with Epidermolysis Bullosa Dystrophica in 1 studies
methyl salicylate: used in over-the-counter liniments, ointments, lotions for relief of musculoskeletal aches and pains; has hemolytic effect on human & sheep erythrocytes; RN given refers to parent cpd; structure in Merck Index, 9th ed, #5990
methyl salicylate : A benzoate ester that is the methyl ester of salicylic acid.
Epidermolysis Bullosa Dystrophica: Form of epidermolysis bullosa characterized by atrophy of blistered areas, severe scarring, and nail changes. It is most often present at birth or in early infancy and occurs in both autosomal dominant and recessive forms. All forms of dystrophic epidermolysis bullosa result from mutations in COLLAGEN TYPE VII, a major component fibrils of BASEMENT MEMBRANE and EPIDERMIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Adverse events (AEs) occurred with similar frequency for Oleogel-S10 (81·7%) compared with control gel (80·7%)." | 3.30 | Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study. ( Bodemer, C; Bruckner, AL; Cunningham, T; Davis, C; Fernandez, MF; Kern, JS; Löwe, S; Murrell, DF; Schauer, F; Sprecher, E; Sumeray, M, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kern, JS | 1 |
| Sprecher, E | 1 |
| Fernandez, MF | 1 |
| Schauer, F | 1 |
| Bodemer, C | 1 |
| Cunningham, T | 1 |
| Löwe, S | 1 |
| Davis, C | 1 |
| Sumeray, M | 1 |
| Bruckner, AL | 1 |
| Murrell, DF | 1 |
1 trial available for methyl salicylate and Epidermolysis Bullosa Dystrophica
| Article | Year |
|---|---|
Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study.
Topics: Betula; Double-Blind Method; Epidermolysis Bullosa; Epidermolysis Bullosa Dystrophica; Humans; Trite | 2023 |